AllPennyStocks.com Nutrien (NTR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

Nutrien (NTR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Nutrien (NTR) reported $10.81 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 3.6%. EPS of $2.61 for the same period compares to $2.65 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $10.67 billion, representing a surprise of +1.31%. The company delivered an EPS surprise of -3.33%, with the consensus EPS estimate being $2.70.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Nutrien performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
  • Potash - Sales volumes - Total: 3,943.00 KTon compared to the 4,039.88 KTon average estimate based on three analysts.
  • Nitrogen - Sales volumes - Total: 2,253.00 KTon versus the three-analyst average estimate of 2,352.95 KTon.
  • Phosphate - Average net selling price - Industrial and feed: 919.00 $/Ton versus the three-analyst average estimate of 911.01 $/Ton.
  • Phosphate - Average net selling price - Fertilizer: 719.00 $/Ton compared to the 726.95 $/Ton average estimate based on three analysts.
  • Net Sales- Downstream- Retail: $8.27 billion versus the five-analyst average estimate of $8.15 billion. The reported number represents a year-over-year change of +3.9%.
  • Total Sales- Upstream and Midstream- Nitrogen: $1.27 billion versus $1.25 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -9.9% change.
  • Total Sales- Upstream and Midstream- Potash: $1.14 billion compared to the $1.14 billion average estimate based on five analysts. The reported number represents a change of +4.6% year over year.
  • Total Sales- Upstream and Midstream- Phosphate: $525 million versus $522.55 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +16.9% change.
  • Retail sales by product line- Crop protection products: $2.76 billion versus the three-analyst average estimate of $2.71 billion. The reported number represents a year-over-year change of +3.3%.
  • Potash sales by geography- Manufactured product- Offshore: $781 million versus $762.8 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +11.4% change.
  • Retail sales by product line- Crop nutrients: $3.54 billion compared to the $3.25 billion average estimate based on three analysts. The reported number represents a change of +4.4% year over year.
  • Net Sales- Eliminations: $-424 million versus $-389.43 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +3.7% change.

View all Key Company Metrics for Nutrien here>>>

Shares of Nutrien have returned +2.5% over the past month versus the Zacks S&P 500 composite's +3.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Research Chief Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Nutrien Ltd. (NTR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Other Penny Stock Movers

When Design Thinking Meets the AI Canvas
Brazilian Developer Jumps 11% as Court Lifts Injunction
Deep Utah Porphyry Intercept Triggers 57% Rally as Drilling Continues Past 550m
Most Popular
{{ index + 1 }}


Back to Top